Osteocel®

Ostoecel® is a cellular bone matrix retaining mesenchymal stem cells and osteoprogenitors that mimics the biological profile of autograft. The proprietary processing technology that produces Osteocel results in a viable bone matrix product that preserves the native mesenchymal stem cells and osteoprogenitors found in marrow-rich bone.

It was the first product available to have the desired beneficial properties of autograft osteoconduction, osteoinducation and osteogenesis and that allows surgeons to provide their patients with a complete solution without the added risk and cost of a secondary procedure. Osteocel grafts have been used since 2005 in more than 30,000 procedures, with no reported adverse events.